Animal experiments using apolipoprotein E-deficient mice have shown that ONO-5430514 attenuates endothelial dysfunction and prevents atherosclerosis, making it a target for the treatment of atherosclerosis [138]. The gene discussed is APOE; the disease is atherosclerosis.